Use of continuous glucose monitoring to introduce adjunctive pramlintide therapy in a patient with type 1 diabetes: A case study

Author： Walker Tomas C.  

Publisher： Blackwell Publishing

ISSN： 1041-2972

Source： Journal of the American Academy of Nurse Practitioners, Vol.23, Iss.10, 2011-10, pp. : 521-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for type 1 diabetes: Is it ready for the clinic?

By D'Anneo Antonella   Rood Pleunie   Bottino Rita   Balamurugan A.   He Jing   Giannoukakis Nick  

Immunologic Research, Vol. 36, Iss. 1-3, 2006-02 ,pp. : 83-89

Humana Press, Inc

Access to resources Recommend Favorite

Autoantibodies to Multiple Islet Autoantigens in Patients with Abrupt Onset Type 1 Diabetes and Diabetes Diagnosed with Urinary Glucose Screening

By Sera Y.   Kawasaki E.   Abiru N.   Ozaki M.   Abe T.   Takino H.   Kondo H.   Yamasaki H.   Yamaguchi Y.   Akazawa S.   Nagataki S.   Uchigata Y.   Matsuura N.   Eguchi K.  

Journal of Autoimmunity, Vol. 13, Iss. 2, 1999-09 ,pp. : 257-265

Academic Press

Access to resources Recommend Favorite

Mesenchymal Stem Cell-Based Therapy for the Treatment of Type 1 Diabetes Mellitus

By  

Current Stem Cell Research & Therapy, Vol. 7, Iss. 3, 2012-05 ,pp. : 179-190

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in insulin gene therapy for type 1 diabetes

By Yoon J.-W.   Jun H.-S.  

Trends in Molecular Medicine, Vol. 8, Iss. 2, 2002-02 ,pp. : 62-68

Elsevier

Access to resources Recommend Favorite

The potential role of dendritic cells in the therapy of Type 1 diabetes

By Lee Chin-Nien   Lew Andrew M   Wu Li  

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 591-606

Future Medicine

Access to resources Recommend Favorite